Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Takeshita (atami, Japan). Novel treatment of eosinophilic bronchitis with allergic fungal sinusitis using mepolizumab. 4023

Member's Comments

No comment yet.

Related content which might interest you: Novel treatment of eosinophilic bronchitis with allergic fungal sinusitis using mepolizumab- One year follow-up. Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Asthma exacerbations and eosinophilic inflammation 6 months after treatment with mepolizumab in refractory eosinophilic asthma Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Clinical outcome of eosinophilic airway inflammation in chronic airway diseases including nonasthmatic eosinophilic bronchitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis Source: Eur Respir J 2014; 43: 1487-1500 Year: 2014 Mepolizumab efficacy in patients with severe eosinophilic asthma and bronchiectasis Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Real-life treatment of severe eosinophilic asthma with mepolizumab Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Response to inhaled corticosteroids in patients with non-asthmatic eosinophilic bronchitis Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more Year: 2020 Epinastine improves cough in eosinophilic bronchitis (atopic cough) Source: Eur Respir J 2001; 18: Suppl. 33, 425s Year: 2001 Mepolizumab in real-life treatment of severe eosinophilic asthma Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Differential treatment response to mepolizumab in severe eosinophilic asthma with nasal polyps Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Principles of antileucotrien therapy at allergic rhinitis and chronicle adenoiditis Source: Annual Congress 2010 - Paediatric asthma, rhinitis and management Year: 2010 Changes in bronchial inflammation during acute exacerbations of chronic bronchitis Source: Eur Respir J 2001; 17: 1112-1119 Year: 2001 Efficacy of montelukast in patients with concomitan persistent allergic rhinitis and asthma Source: Eur Respir J 2006; 28: Suppl. 50, 663s Year: 2006 Evaluation of bronchial hyperreactivity and hypersensitivity in asthmatics and bronchitis patients Source: Eur Respir J 2004; 24: Suppl. 48, 587s Year: 2004 Airway inflammation in non-eosinophilic atopic asthma: comparisons with eosinophilic atopic asthma and COPD Source: Eur Respir J 2005; 26: Suppl. 49, 733s Year: 2005 Persistent sputum eosinophilia in patients with difficult-to-treat asthma Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up Year: 2010 Different treatment courses with inhaled corticosteroids for eosinophilic bronchitis Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura Year: 2011 Treatment of co-morbid allergic asthma and perennial allergic rhinitis with the anti-IgE agent omalizumab Source: Eur Respir J 2003; 22: Suppl. 45, 203s Year: 2003 Rapid Benralizumab effectiveness in patients with severe eosinophilic asthma and bronchiectasis Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020